We describe the continuous-flow automation of a quenching fluoroimmunoassay for determination of the antibiotic gentamicin in serum. In the flow system, sample is mixed with fluorescein-labeled gentamicin, followed by antiserum, and after a short incubation the fluorescence is measured. The intrinsic blank signal of each sample is corrected for during its single passage through the system by pumping antiserum discontinuously, so as to divide the final stream into sections corresponding to conventional separate assay and blank mixtures. Analyses time for each sample is 6 mm, and 20 samples can be run per hour. Sensitivity, precision, and accuracy are adequate for clinical purposes, and assays of patients' samples correlate satisfactorily with the results of manual quenching and polarization fluoroimmunoassays, and plate diffusion bioassay.
The potential for simple automation is one of the attractions of those nonisotopic immunoassays that may be performed without the need for a separation step. Discrete automation of homogeneous enzyme immunoassay has been reported, notably for the determination of anti-epileptic drugs (1,2) and thyroxine (3) in serum. Spencer et al. (4) showed the feasibility of a continuous-flow fluoroimmunoassay (FIA) based on fluorescence polarization measurements.
The present report describes the continuous-flow automation of a quenching FIA method for serum gentamicin, which is based on the fluorescence quenching of fluoresceinlabeled gentamicin upon its binding by antibodies to gentamicmn. The manual assay, its usefulness in monitoring antibiotic therapy, and its merits as compared with other methods for gentamicin have been described previously (5).
A brief preliminary account of this work has already been presented (6). Figure 1 ) each sample was mixed with a continuously flowing air-segmented stream of FTC-gentamicin, followed by the introduction of antiserum. This final assay stream, after an incubation period determined by the length of the second mixing coil, passed through the fluoronephelometer flow cell. Antiserum was placed in a container, which was stood on the sampler tray cover so that when the sampler arm was in the sampling position, sample was aspirated through a probe in position A of the arm and antiserum through a probe in position B. The wash reservoirs of positions A and B were supplied with buffer at 2 mL/min. Sampling and wash times were 2 and 1 mm, respectively.
Materials and Methods

Reagents
Blank Correction
The system was "phased" by adjusting the lengths of the transmission lines between the sampler and the pump so that of the first section from that of the second eliminated the sample blank contribution (Figure 2 ). The result (Q)gave the extent of quenching of FTC-gentamicin in the assay mixture, less the value of the antiserum blank signal. Because the antiserum blank was constant throughout a given assay, it was not corrected for unless otherwise stated.
Assay Procedure
Standards were prepared by adding gertamicin reference solution to pooled normal human serum. A working 400-fold dilution in buffer containing Triton X-100 detergent (1 mL/L) was prepared from the stock FTC-gentamicin
solution. Antiserum was diluted 160-fold in buffer. Serum samples or standards (50 cL) were diluted 100-fold in buffer and transferred to cups in the sampler tray. Typically, a set of standards was included at the start, middle, and end of each run. Samples were run singly. All experiments were done at room temperature.
From the recorder tracing, Q values (the plateau signal of the first section of each group subtracted from that of the second) for samples and standards were determined and the gentamicin content of each sample was read from a standard curve plotted in linear-log form. If logit transformation of data was desired, the antiserum blank signal was separately determined (by substituting the other assay reagents with buffer) and added to each Qvalue, so as to obtain the true extent of quenching of FTC-gentamicin. This was then used directly in place of the "fraction bound" of labeled ligand in the usual logit formula (7, 8).
Manual Fluorimmunoassay Methods
Manual quenching and polarization FIA methods were performed as described previously (5). 
Results
Flow System
An initial problem of carryover was overcome by combining entirely plastic construction of the flow system (except for the flow cell and stainless-steel probes and nipples) with the use of the tris(hydroxymethyl)ammnomethane buffer containing magnesium ions. A test sample containing 8mg of gentamicin per liter then gave no detectable carryover into a sample containing no gentamicin, and a sample containing 64 mg/L gentamicin gave a carryover of less than 0.5 mg/L into a sample containing no gentamicin.
I(-n
The interval between commencing aspiration of a pre-diluted sample and its complete passage through the flow cell was 6 mm. The incubation period between introduction of antiserum and passage of the assay stream through the flow cell was 112 s, which is less than the time (about 5 mm) necessary for complete reaction in this system (5).
Standard Curve
The presence of gentamicin in serum samples or standards resulted in reduced quenching of FTC-gentamicin fluorescence because of competition for the limited amount of antibody (Figures 3 and 4) . The maximum extent of quenching averaged 14% of the unquenched signal of FTC-gentamicmn, and the antiserum blank was typically about 3% of this signal. 
Analytical Evaluation
Precision.
Gentamicin reference solution was added to pooled normal human serum to give concentrations of 2.5 and 5.0 mg/L. Within-assay CV (20 determinations) was 7.3 and 5.9%, respectively.
Between-assay CV (assays on 20 consecutive working days) was 9.6 and 10.0%, respectively. The patients' sera were assayed by the automated quenching FIA, by manual quenching and polarization FIA, and by bioassay. Five trough samples were found by bioassay to be below the sensitivity limit of 1.25 mg/L. Correlation between automated FIA and bioassay for the remaining 35 samples was characterized by a correlation coefficient (r) of 0.85. Correlation with manual quenching and polarization FIA methods (40 patients' samples each) gave r = 0.97 and r = 0.95, respectively.
Discussion
There was initially excessivecarryover in the automated. system, which appeared to be due to binding of the gentamicin polycation to presumed anionic sites on glass surfaces. If glass components were eliminated, the presence of 10 mmol/L magnesium ions was sufficient to block any remaining sites and permit satisfactory wash of gentamicin through the system.
Correction for the intrinsic fluorescence (blank) of serum samples is necessary in many fluorimetric methods and was made possible in the automated system by pumping the antiserum discontinuously, in appropriate phase with the sample stream.
Only a single passage of each sample through the system was required.
The precisetiming characteristic of the continuous-flow technique enabled the immunoassay incubation time to be reduced to less than 2 mm by making a pre-equilibrium end point measurement. By these means, a result could be made available within 6 mm of the aspiration of a pre-diluted sample, given prior construction of the standard curve. Satisfactory signal plateaus were achieved by division of the final assay stream into 1-mm sections, fixing the sampling rate at 20/h.
The sample pre-dilution was chosen to give optimum assay performance in the range 1 to 8 mgfL (Figure 3) , which encompasses commonly encountered peak and trough concen- The recorder tracing provided a continuous indication of satisfactory performance of the flow system, and samples were therefore run only singly in the evaluation studies. Precision and accuracy were generally within limits considered suitable for the monitoring of gentamicin therapy (13). Increase of the immunoassay incubation period would allow development of larger quenching effects and probably improve precision towards levels attainable using the manual method (5). Automated assay of patients' samples showed good correlation with established manual quenching (5) and polarization (14) FIA techniques. Poorer agreement with the widely used plate diffusion method was in accord with previous experience (5, 14), and may be a reflection of the relative inaccuracy of the bioassay.
